WESTBOROUGH, Mass., Jan. 6, 2014 (GLOBE NEWSWIRE) -- An analysis of the MarginProbe post-market study of patients with ductal carcinoma in situ (DCIS) conducted in 3 centers in Germany was presented during the 2013 CTRC-AACR San Antonio Breast Cancer Symposium. The results were presented by Dr. Marc Thill, Head of the Department of Gynecology and Obstetrics and the Breast Cancer Center at Agaplesion Markus Hospital, Frankfurt. In patients with DCIS, adjunctive use of MarginProbe significantly improved surgical outcomes by increasing surgeons’ ability to identify and immediately resect positive margins, reducing the number of patients requiring re-excision by over 50%.
Help employers find you! Check out all the jobs and post your resume.
